The Role of the Oncology Patient Navigator Webinar
presented by Tricia Strusowski, MS, RN, Manager
February 28, 2017
Oncology Solutions is pleased to collaborate on a series of quarterly navigation and survivorship webinars with The Academy of Oncology Nurse & Patient Navigators (AONN+). This first webinar in the series, “The Role of the Oncology Patient Navigator,” includes the following topics:
- Definition, History, Goals, & Models of Navigation
- CoC Chapter 3: Continuum of Care
- Institute of Medicine Conceptual Framework
- AONN+ Mission & Vision/ONS and AOSW Position Statement on Navigation
- Patient Flow & Managing Transitions
- Value-Based Care & the Oncology Care Model
- Reporting Tools & Navigation Metrics
Additionally, Tricia serves as Project Leader on the Evidence into Practice Navigation Metrics Subcommittee for AONN+, which recently spearheaded the development of standardized metrics for navigation. To read more, click here.
Prospective Payment System–Exempt Cancer Hospitals White Paper
by Brian Leigh
In an effort to reduce the rapidly escalating costs of providing healthcare in the U.S., Congress implemented the new inpatient PPS in the mid-1980s. This system reduced the amount of Medicare reimbursement that hospitals would receive and incentivized facilities to become more efficient by decreasing their costs for inpatient care. Certain specialty hospitals that met a number of requirements were exempted from PPS, and this group included hospitals that focused solely on the treatment of cancer. These exempted facilities would continue to be reimbursed based on the cost-plus method and would not shift to the new PPS reimbursement method. There are currently eleven PPS-Exempt Cancer Hospitals operating in the U.S., ten of which are NCI-designated comprehensive cancer centers. While advocates for these facilities claim that the cost-based reimbursement method allows them to provide superior care and improve patient outcomes, there are also detractors who feel that PCHs should be under the same reimbursement system as all other hospitals . Read more.
The world of cancer care will look profoundly different in 2021. With the adoption of a value-based framework, providers will be reimbursed based on cost and quality—not volume—and patients will choose to entrust their care to those with a proven record of success. President-Elect Trump’s promises to repeal the Affordable Care Act and reform the Medicare program may substantially impact the economics of oncology practice, patient access to appropriate care, and the speed at which CMS moves toward pay-for-performance models. These unknowns are compounded by uncertainty surrounding how the new administration will approach hot topics like drug pricing and value-based purchasing, site-neutral hospital payments, and 340B eligibility. Oncology administrators should closely monitor these policy decisions and prepare flexible strategies for mitigating the impact on their programs and patients.
Faced with new complexities—what future are we planning for and how does it affect the physicians, technologies, and services needed to succeed in cancer? Cancer 2021 requires a transformational, actionable strategic plan now. Listen below to learn more.
Oncology's Value-Oriented Framework
A number of excellent strategic planning tools have been published by consultancies and academia, but we have found that they often lack the necessary specificity for oncology and, more importantly, do not fully address the all-important question for healthcare organizations—how do we plan for an uncertain, value-based future? Read more
Developing an Oncology IT Strategy
by Ryan P. Langdale, MBA, and Alex Glonek
Cancer has become a disease characterized by its data. Insurance companies demand cost and utilization data, searching for a meaningful way to optimize value. Patients request test results, lab values, and physician notes, seeking to become shared decision-makers in their care. Researchers, pharmaceutical manufacturers, and others seek clinical data in an effort to further our biological understanding of the disease and provide clinicians with novel treatment compounds and decision support. Everyone wants cancer data, and yet the demand for quality oncology data far outstrips the provider community's ability to collect and deliver such data. Read more
Patient Navigation Metrics
Patient navigation programs have achieved more traction over the last several years, including the release of the 2013 ONS Nurse Navigator Core Competencies and the 2012 Commission on Cancer (CoC) Standard 3.1, Patient Navigation Process. While these guidelines and standards have provided cancer programs with additional justification to support the navigator role, it is incredibly important for managers and administrators to be able to report the true impact that navigation programs have on cancer patients as well as the cancer program. Read more
Strategic Planning: A Roadmap to Follow to Ensure a Successful Oncology Service Line
Oncology defies the norm for most hospital business - existing primarily in the outpatient setting, spanning multiple departments - and requires high capital investment, including spending for a range of supportive care services critical for its population. Many hospitals also find it challenging to clearly track the flow of oncology funds across multiple departments and disciplines. Yet for successful program growth, it is important that strategic planning for oncology occur within this broader context. Read more
Delivering "Value" in Cancer Care
by Kelley D. Simpson, Elizabeth Simmer, and Alina Maleski Smith
Value is something the consumer expects in the marketplace, where demanding a high quality product at a low cost is common practice. However, healthcare has historically not been held to a similar standard as other industries when delivering on this demand. Driven by recent pay-for-performance efforts, the need for this "norm" to change has the attention of patients, providers and policy-makers. Read more
Practice Benchmarking in the Age of Targeted Auditing: Radiation Oncology
by Ryan P. Langdale, MBA and Ben F. Holland, MBA
October 8, 2013
The frequency and sophistication of health care reimbursement auditing have progressed rapidly in recent years, leaving many oncologists wondering whether their private practices would survive a full-scale government investigation
Bringing Together the PSA & the MSA
by Matt Cox, MPH and Kelley D. Simpson
Many hospitals and oncology practices exploring partnerships adopt a Professional Services Agreement (PSA). In fact, the PSA has emerged as one of the most popular integration strategies across the country. One recent study found that 42 percent of the hospitals surveyed already use a PSA model, while an additional 14 percent of hospitals were contemplating a PSA with their oncologists within the next 12 months.
Delivering Value in Cancer Care
by Ryan P. Langdale, MBA
Americans are accustemed to the idea of "value" or getting the most from their dollar. Whether a company is selling Value Meals or Volvos, the path to a competitive marketplace advantage relies on a succinct value proposition. Cancer care remains one of the few areas with the most to gain from coordinated, value-based reform.
Oncology Nurse Navigators
A snapshot of their educational background, compensation, and day-to-day roles and responsibilites
by Kelley D. Simpson and Sharon L. Francz
The life-changing event of a cancer diagnosis causes fear, anxiety, and confusion for patients and families. Hospital and health systems nationwide are increasingly turning to oncology nurse navigators to provide needed support and guidance to help patients and families traverse the complexities of the cancer care delivery system.